Ulrich Abshagen

Arthro Kinetics develops manufactures and markets advanced biological implants for joint regeneration and surgical instrument and access systems for endoscopic spine surgery. The Company aims to develop a portfolio of biological implants for insertion by endoscopic spine surgery techniques, thereby setting new standards of surgical care. The Company has developed and is marketing CaReS, its first biological cartilage repair product, and K.I.S.S., its comprehensive spinal surgical instruments system for endoscopic spinal access and surgical intervention.

MISTRAL Media AG operates as an investment holding company, which engages in the entertainment and media business. It focuses on the marketing of television production rights, acquisition of legal rights involving legal financing, as well as the acquisition of participating interests and other financial assets. The company was founded on April 22, 1995 and is headquartered in Frankfurt, Germany.

Heidelberg Innovation Fonds Management GmbH (Heidelberg Innovation) is an independent German venture capital firm which was founded in 1997 by Dr. Ulrich Abshagen. In addition to providing financial capital, Heidelberg Innovation's 'network and knowledge capital', in the form of entrepreneurial experience, technical expertise and their network of experts and contacts, is a decisive added value for their investee companies. Based in Leimen, the firm manages the Heidelberg Innovation BioScience Venture II, Heidelberg Innovation Parallel Participation and the Heidelberg Innovation BioScience Venture I funds for investors including the European Investment Fund, insurance companies, banks, fund-of-fund investors and private individuals.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec® Histology kit and CINtec® Cytology kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4™ antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results. mtm laboratories AG also has programs to identify and develop biomarker based diagnostics for other cancer indications. With its extensive and ever increasing network of clinical research institutions, academic research organizations, and medical professionals active in the field of oncology and molecular pathology, mtm has established a rapid, integrated process for the successful identification and clinical validation of molecular markers associated with cancer.

Digilab, Inc. designs, develops, manufactures and markets molecular spectroscopy systems. The firm provides solutions for scientific discovery in life sciences, analytical chemistry, and diagnostics markets. Its products span DNA sample preparation systems for sequencing, protein and DNA micro arrayers, live cell arrayers, proteome preparation systems, nano and micro fluidic handling, and Raman compound identification. The company was founded in 1970 by Sidney Braginsky and is headquartered in Holliston, MA.

Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany.

Abshagen Consulting GmbH provides business consulting services. The private company is based in Weinheim, Germany. The German company was founded in 1995. The CEO is Ulrich Abshagen.

Arthro Kinetics AG researches, develops, manufactures and sells biological implants. The company was founded in 1999 and is headquartered in Bebenhausen, Germany.